Real-time enrollment status for this liver cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:32 AM UTC
| NCT Number | NCT06921785 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,220 participants |
| Active Locations | 35 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 14, 2026 (6 days ago) |
As of July 20, 2026: Clinical trial NCT06921785 is currently recruiting participants. This phase3 study for liver cancer is actively seeking new participants at 35 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06921785 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06921785 was last updated 6 days ago (July 14, 2026). HelloStudys verifies this status automatically.